Mechanical loading and TGF-β change the expression of multiple miRNAs in tendon fibroblasts

Journal of Applied Physiology

Volumn 113, Issue 1, 2012, Pages 56-62

  Mendias, Christopher L ^a   Gumucio, Jonathan P ^a   Lynch, Evan B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Micro ribonucleic acid; Scleraxis; Tenomodulin; Transforming growth factor

Indexed keywords

MICRORNA; TRANSFORMING GROWTH FACTOR BETA;

ACHILLES TENDON; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; MALE; MECHANICS; METABOLISM; RAT;

ACHILLES TENDON; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLASTS; MALE; MECHANICAL PROCESSES; MICRORNAS; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863301940     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00301.2012     Document Type: Article

References (53)

1. Anand S, Cheresh DA. MicroRNA-mediated regulation of the angiogenic switch. Curr Opin Hematol 18:171-176, 2011.
2. Archambault JM, Jelinsky SA, Lake SP, Hill AA, Glaser DL, Soslowsky LJ. Rat supraspinatus tendon expresses cartilage markers with overuse. J Orthop Res 25:617-624, 2007. (Pubitemid 46730514)
3. Aström M, Rausing A. Chronic achilles tendinopathy. A survey of surgical and histopathologic findings. Clin Orthop Rel Res 151-164, 1995.
4. Bauersachs J. Regulation of myocardial fibrosis by microRNAs. J Cardiovasc Pharmacol 56:454-459, 2010.
5. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11:R90, 2010.
6. Bhatnagar S, Kumar A, Makonchuk DY, Li H, Kumar A. Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation. J Biol Chem 285:6401-6411, 2010.
7. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNAtarget recognition. PLoS Biol 3:e85, 2005.
8. Büssing I, Slack FJ, Grosshans H. Let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14:400-409, 2008.
9. Callis TE, Deng Z, Chen JF, Wang DZ. Muscling through the microRNA world. Exp Biol Med (Maywood) 233:131-138, 2008. (Pubitemid 351231545)
10. Carlson ME, Conboy MJ, Hsu M, Barchas L, Jeong J, Agrawal A, Mikels AJ, Agrawal S, Schaffer DV, Conboy IM. Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 8:676-689, 2009.
11. Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J, Matías-Guiu X, Cano A, Oliva E, Palacios J. Micro-RNA signature of the epithelial- mesenchymal transition in endometrial carcinosarcoma. J Pathol 223:72-80, 2011.
12. Docheva D, Hunziker EB, Fässler R, Brandau O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25:699-705, 2005. (Pubitemid 40096590)
13. Drummond MJ, Mccarthy JJ, Sinha M, Spratt HM, Volpi E, Esser KA, Rasmussen BB. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics 43:595-603, 2011.
14. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, Gordon L, Hendrix M, Hourlier T, Johnson N, Kähäri AK, Keefe D, Keenan S, Kinsella R, Komorowska M, Koscielny G, Kulesha E, Larsson P, Longden I, McLaren W, Muffato M, Overduin B, Pignatelli M, Pritchard B, Riat HS, Ritchie GRS, Ruffier M, Schuster M, Sobral D, Tang YA, Taylor K, Trevanion S, Vandrovcova J, White S, Wilson M, Wilder SP, Aken BL, Birney E, Cunningham F, Dunham I, Durbin R, Fernández-Suarez XM, Harrow J, Herrero J, Hubbard TJP, Parker A, Proctor G, Spudich G, Vogel J, Yates A, Zadissa A, Searle SM. Ensembl 2012. Nucleic Acids Res 40:D84-90, 2012.
15. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601, 2008. (Pubitemid 351627379)
16. He X, Eberhart JK, Postlethwait JH. MicroRNAs and micromanaging the skeleton in disease, development and evolution. J Cell Mol Med 13:606-618, 2009.
17. Heinemeier K, Langberg H, Olesen JL, Kjaer M. Role of TGF-β1 in relation to exercise-induced type I collagen synthesis in human tendinous tissue. J Appl Physiol 95:2390-2397, 2003. (Pubitemid 37444984)
18. Kannus P. Structure of the tendon connective tissue. Scand J Med Sci Sports 10:312-320, 2000.
19. Khan K, Cook J. The painful nonruptured tendon: clinical aspects. Clin Sports Med 22:711-725, 2003. (Pubitemid 37175573)
20. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84:649-698, 2004. (Pubitemid 38365495)
21. Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H. MicroRNA-30a inhibits epithelialtomesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer 130:2044-2053, 2012.
22. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294:853-858, 2001. (Pubitemid 33032103)
23. Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104:20350-20355, 2007.
24. Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer 47:2166-2174, 2011.
25. Lorda-Diez CI, Montero JA, Martinez-Cue C, Garcia-Porrero JA, Hurle JM. Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem 284:29988-29996, 2009.
26. Ludolph DC, Konieczny SF. Transcription factor families: muscling in on the myogenic program. FASEB J 9:1595-1604, 1995. (Pubitemid 26013197)
27. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, Sasaki T, Stavnezer E, Iannotti J, Schweitzer R, Ilic D, Baskaran H, Sakai T. Conversion of mechanical force into TGF-β-mediated biochemical signals. Curr Biol 21:933-941, 2011.
28. Magnusson SP, Narici MV, Maganaris CN, Kjaer M. Human tendon behaviour and adaptation, in vivo. J Physiol 586:71-81, 2008.
29. Mccarthy JJ. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 1779:682-691, 2008.
30. Mccarthy JJ. The MyomiR network in skeletal muscle plasticity. Exerc Sport Sci Rev 39:150-154, 2011.
31. Mccarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE. Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 39:219-226, 2009.
32. Mendias CL, Bakhurin KI, Faulkner JA. Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 105:388-393, 2008.
33. Mendias CL, Gumucio JP, Bakhurin KI, Lynch EB, Brooks SV. Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. J Orthop Res 30:606-612, 2012.
34. Michna H, Hartmann G. Adaptation of tendon collagen to exercise. Int Orthop 13:161-165, 1989. (Pubitemid 19250554)
35. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumder S. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283:29897-29903, 2008.
36. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, Takada S, Lotz MK, Ueno-Kudo H, Asahara H. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173-1185, 2010.
37. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 134:2697-2708, 2007. (Pubitemid 47225965)
38. Nielsen S, Scheele C, Yfanti C, Åkerström T, Nielsen AR, Pedersen BK, Laye M. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol 588:4029-4037, 2010.
39. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86-89, 2000.
40. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dünker N, Schweitzer R. Recruitment and maintenance of tendon progenitors by TGFβ signaling are essential for tendon formation. Development 136:1351-1361, 2009.
41. Pufe T, Petersen WJ, Mentlein R, Tillmann BN. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand J Med Sci Sports 15:211-222, 2005. (Pubitemid 41032385)
42. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4:197-205, 2011.
43. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology 45:508-521, 2006.
44. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906, 2000. (Pubitemid 30130993)
45. Rissland OS, Hong SJ, Bartel DP. MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes. Mol Cell 43:993-1004, 2011.
46. Safdar A, Abadi A, Akhtar M, Hettinga BP, Tarnopolsky MA. miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLos One 4:e5610, 2009.
47. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 3:1101-1108, 2008. (Pubitemid 351818697)
48. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13, 2004.
49. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512, 1999. (Pubitemid 29297917)
50. Tomé M, López-Romero P, Albo C, Sepúlveda JC, Fernández-Gutiérrez B, Dopazo A, Bernad A, González MA. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 18:985-995, 2011.
51. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14:369-381, 2008.
52. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, Gregorevic P. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 286:13805-13814, 2011.
53. Xu Y, Murrell GA. The basic science of tendinopathy. Clin Orthop Relat Res 466:1528-1538, 2008.